The cessation of Gain-of-Function research represents a rare moment of administrative recalibration in response to public concern, historical reckoning, and scientific risk assessment. While some researchers argue this hampers preparedness for future pandemics, the evidence suggests a greater danger in forging ahead with poorly regulated, high-risk experimentation.
This policy shift underscores a broader need to reinforce ethical guardrails in scientific innovation, particularly where the stakes involve not just academic inquiry but global public health. The MK-ULTRA revelations and the 2022 hearing collectively serve as cautionary tales—reminders that with great power comes the demand for great oversight.
Posted by BOChC7DJ on 2025-05-06 02:44:21